Alongside their blood sugar-lowering effects, GLP-1 medications have been found to: Innovative Vitality providers commonly prescribe GLP-1 medications and work closely with patients to monitor their progress every step of the way
In the CNS, it is well recognized that an immense diversity of neurons alongside glial cell populations, with both lineages exhibiting significant cellular heterogeneity (Siletti et al., 2023
Glycaemic regulation models: In hyperglycaemic clamp models and oral glucose tolerance test paradigms in rodents, GLP-1R/GIPR co-activation with concurrent GCGR engagement did not produce the hyperglycaemic signal that might be predicted from glucagon receptor activation alone
Yeast infections (candidiasis) are not listed as a common or direct side effect of GLP-1 receptor agonists in the large-scale clinical trials used for FDA approval of branded medications like Wegovy or Zepbound
(PubMed) Stone KL, Lui LY, Christen WG, et al